Aiken C
Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, 37232-2363, USA.
Virology. 1998 Aug 15;248(1):139-47. doi: 10.1006/viro.1998.9254.
Optimal HIV-1 infectivity requires the presence of both the viral factor Nef and the cellular protein cyclophilin A (CyPA) during virion assembly. These two proteins are integral components of HIV-1 particles. Both CyPA and Nef facilitate a step in the viral life cycle occurring between penetration and reverse transcription, suggesting a common mechanism of action. Experiments were performed to test the potential interplay of Nef- and CyPA-mediated enhancement of HIV-1 infectivity. In single-cycle infection assays, nef-defective virions were partially resistant to cyclosporin A (CsA), a drug that inhibits the binding of CyPA to the HIV-1 Gag precursor and CyPA incorporation into virions. Genetic dissection of the relative contributions of Nef and the cyclophilin A-Gag interaction to HIV-1 infectivity demonstrated the independence of these two effects. Nef was not required for incorporation of CyPA into HIV-1 virions and vice-versa. Surprisingly, CyPA-deficient virions remained sensitive to inhibition by CsA, in a manner that depended strongly on the presence of a functional nef gene. These results demonstrate that Nef and CyPA act independently to render HIV-1 particles fully infectious. They further suggest that in addition to blocking the CyPA-Gag interaction, CsA can also inhibit HIV-1 replication through a novel mechanism involving suppression of Nef-directed enhancement of virus infectivity.
最佳的HIV-1感染性要求在病毒体组装过程中同时存在病毒因子Nef和细胞蛋白亲环素A(CyPA)。这两种蛋白质是HIV-1颗粒的组成成分。CyPA和Nef都促进病毒生命周期中发生在穿透和逆转录之间的一个步骤,提示存在共同的作用机制。开展实验以测试Nef和CyPA介导的HIV-1感染性增强之间的潜在相互作用。在单循环感染试验中,缺乏nef的病毒体对环孢菌素A(CsA)有部分抗性,CsA是一种抑制CyPA与HIV-1 Gag前体结合以及CyPA掺入病毒体的药物。对Nef和亲环素A-Gag相互作用对HIV-1感染性的相对贡献进行基因剖析,结果表明这两种效应相互独立。CyPA掺入HIV-1病毒体不需要Nef,反之亦然。令人惊讶的是,缺乏CyPA的病毒体对CsA抑制仍保持敏感,其方式强烈依赖于功能性nef基因的存在。这些结果表明,Nef和CyPA独立发挥作用以使HIV-1颗粒具有完全感染性。它们还进一步提示,除了阻断CyPA-Gag相互作用外,CsA还可通过一种涉及抑制Nef介导的病毒感染性增强的新机制来抑制HIV-1复制。